Home › Funds › Sicart Associates LLC › GH

Sicart Associates LLC position in GH

GUARDANT HEALTH INC · Health Care

Sicart Associates LLC reported holding 181,030 shares of GH (GUARDANT HEALTH INC) in its Q3 2026 13F filing — a position valued at US$28.7M, representing 6.96% of its reported portfolio and ranking #3 among its reported holdings. Sicart Associates LLC has disclosed GH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)181.03K sh
Reported value held$28.71M
Portfolio Weight6.96%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Sicart Associates LLC's GH position evolved

Sicart Associates LLC first disclosed a stake in GH in Q3 2023 at 95,925 shares (US$2.8M). The position peaked in Q2 2026 at 231,015 shares, worth US$34.7M. Across 13 filings, Sicart Associates LLC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 181,030 shares valued at US$28.7M — a reduction of -49,985 shares quarter over quarter.. Notable position changes include a 58% increase in Q1 2024 (shares rose 40% over the following quarter), a 39% increase in Q3 2025 (shares rose 63% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 95.92K $2.84M New
Q4 2023 92.95K $2.51M Reduce
Q1 2024 146.59K $3.02M Add
Q2 2024 145.98K $4.22M Hold
Q3 2024 146.30K $3.36M Hold
Q4 2024 140.33K $4.29M Reduce
Q1 2025 137.59K $5.86M Reduce
Q2 2025 165.46K $8.61M Add
Q3 2025 230.08K $14.38M Add
Q4 2025 228.20K $23.31M Reduce
Q1 2026 230.10K $21.25M Add
Q2 2026 231.01K $34.66M Hold
Q3 2026 181.03K $28.71M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GH and 13F data

GH (GUARDANT HEALTH INC) is a Health Care company. 58 other funds we track also report a position in GH — the largest reported positions include Deep Track Capital, LP (US$509.1M), FEDERATED HERMES, INC. (US$445.6M), FULLER & THALER ASSET MANAGEMENT, INC. (US$394.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GH

All GH fund holders →

FAQ

How long has Sicart Associates LLC held GH?

Sicart Associates LLC has disclosed GH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Sicart Associates LLC's current position in GH?

As of Q3 2026, Sicart Associates LLC holds 181.03K shares of GH (GUARDANT HEALTH INC), valued at $28.71M, representing 6.96% of its reported portfolio and ranking #3.

Has Sicart Associates LLC been buying or selling GH?

In the latest 13F filing (Q3 2026), Sicart Associates LLC reduced its position in GH. The position peaked in Q2 2026 at 231.01K shares.

Which other funds hold GH?

Other major institutional holders of GH include Deep Track Capital, LP, FEDERATED HERMES, INC., FULLER & THALER ASSET MANAGEMENT, INC., among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.